S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PYPL   66.60 (+0.05%)
NASDAQ:XOMA

XOMA (XOMA) Stock Price, News & Analysis

$23.34
+0.19 (+0.82%)
(As of 03/27/2024 ET)
Today's Range
$23.00
$23.48
50-Day Range
$19.10
$26.32
52-Week Range
$13.48
$26.83
Volume
7,215 shs
Average Volume
21,305 shs
Market Capitalization
$271.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.00

XOMA MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
217.1% Upside
$74.00 Price Target
Short Interest
Healthy
2.36% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.22
Upright™ Environmental Score
News Sentiment
0.97mentions of XOMA in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.73) to ($1.36) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.06 out of 5 stars

Medical Sector

240th out of 939 stocks

Pharmaceutical Preparations Industry

103rd out of 435 stocks

XOMA stock logo

About XOMA Stock (NASDAQ:XOMA)

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA Stock Price History

XOMA Stock News Headlines

XOMA Declares Quarterly Preferred Stock Dividends
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
XOMA to Present at Upcoming Investor Conferences in March
XOMA Mar 2024 20.000 put
XOMA Jun 2024 25.000 call
XOMA Agrees to Acquire Kinnate Biopharma
See More Headlines
Receive XOMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/08/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:XOMA
CUSIP
98419J10
Employees
13
Year Founded
1981

Price Target and Rating

Average Stock Price Target
$74.00
High Stock Price Target
$74.00
Low Stock Price Target
$74.00
Potential Upside/Downside
+217.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-40,830,000.00
Net Margins
-886.91%
Pretax Margin
-858.16%

Debt

Sales & Book Value

Annual Sales
$4.76 million
Book Value
$7.72 per share

Miscellaneous

Free Float
11,021,000
Market Cap
$271.44 million
Optionable
Optionable
Beta
0.58

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

XOMA Stock Analysis - Frequently Asked Questions

Should I buy or sell XOMA stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for XOMA in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" XOMA shares.
View XOMA analyst ratings
or view top-rated stocks.

What is XOMA's stock price target for 2024?

1 analysts have issued 1 year price objectives for XOMA's stock. Their XOMA share price targets range from $74.00 to $74.00. On average, they predict the company's stock price to reach $74.00 in the next year. This suggests a possible upside of 217.1% from the stock's current price.
View analysts price targets for XOMA
or view top-rated stocks among Wall Street analysts.

How have XOMA shares performed in 2024?

XOMA's stock was trading at $18.50 at the beginning of the year. Since then, XOMA stock has increased by 26.2% and is now trading at $23.34.
View the best growth stocks for 2024 here
.

When is XOMA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our XOMA earnings forecast
.

How were XOMA's earnings last quarter?

XOMA Co. (NASDAQ:XOMA) issued its earnings results on Friday, March, 8th. The biotechnology company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.36) by $0.13. The biotechnology company had revenue of $1.83 million for the quarter, compared to analysts' expectations of $1.01 million. XOMA had a negative net margin of 886.91% and a negative trailing twelve-month return on equity of 25.17%.

What is John Varian's approval rating as XOMA's CEO?

11 employees have rated XOMA Chief Executive Officer John Varian on Glassdoor.com. John Varian has an approval rating of 73% among the company's employees.

What other stocks do shareholders of XOMA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other XOMA investors own include Cytokinetics (CYTK), Alnylam Pharmaceuticals (ALNY), Ascent Solar Technologies (ASTI), CTI BioPharma (CTIC), OPKO Health (OPK), Uranium Energy (UEC), Gilead Sciences (GILD), NXP Semiconductors (NXPI) and Ekso Bionics (EKSO).

Who are XOMA's major shareholders?

XOMA's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.67%), Vanguard Group Inc. (3.67%), Opaleye Management Inc. (2.18%), Stonepine Capital Management LLC (2.18%), Dimensional Fund Advisors LP (0.22%) and Barclays PLC (0.09%). Insiders that own company stock include Bradley Sitko, Bvf Partners L P/Il, James R Neal, James R Neal, Owen Hughes and Thomas M Burns.
View institutional ownership trends
.

How do I buy shares of XOMA?

Shares of XOMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XOMA) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners